Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients

BACKGROUND: Most solid organ transplant recipients did not develop an appreciable serologic response after 2 doses of the mRNA SARS-CoV-2 vaccine. METHODS: We analyzed the humoral response after a third dose of the BNT162b2 vaccine in 130 kidney transplant recipients, compared to 48 health care work...

Descripción completa

Detalles Bibliográficos
Autores principales: Grupper, Ayelet, Rabinowich, Liane, Ben-Yehoyada, Merav, Katchman, Eugene, Baruch, Roni, Freund, Tal, Hagin, David, Shlomo, Shani Ben, Schwartz, Doron, Schwartz, Idit F., Shashar, Moshe, Bassat, Orit Kliuk-Ben, Halperin, Tami, Turner, Dan, Saiag, Esther, Goykhman, Yaacov, Shibolet, Oren, Levy, Sharon, Houri, Inbal, Katchman, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885288/
https://www.ncbi.nlm.nih.gov/pubmed/35346486
http://dx.doi.org/10.1016/j.transproceed.2022.02.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885288/
https://www.ncbi.nlm.nih.gov/pubmed/35346486
http://dx.doi.org/10.1016/j.transproceed.2022.02.011

Ejemplares similares